Sign in

CIK 0001590560

  • Large accelerated filer

uniQure N.V.

Sign in to watch
Ticker
QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 339-970-7000
Business address
PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
Former names
uniQure B.V.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$192,950
in 1 filing, $193K under 10b5-1 plans

Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Meek David D. −$193K Director sold 23% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-10 Gut Robert Director Exercise or conversion 10b5-1 +2,645 $16.04 $42K 34,987
2026-06-10 Gut Robert Director Sale 10b5-1 −2,645 $26.07 $69K 32,342
2026-06-10 Gut Robert Director Sale 10b5-1 −3,127 $26.03 $81K 29,215
2026-06-10 Gut Robert Director Sale 10b5-1 −1,780 $26.05 $46K 27,435
2026-06-10 Gut Robert Director Grant or award 10b5-1 +7,550 34,985
2026-06-10 Gut Robert Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −2,645 0
2026-06-10 Gut Robert Director Grant or award · Stock Option (Right to Buy) 10b5-1 +13,980 13,980
2026-06-10 Springhorn Jeremy P. Director Grant or award +7,550 45,244
2026-06-10 Springhorn Jeremy P. Director Grant or award · Stock Option (Right to Buy) +13,980 13,980
2026-06-10 POST LEONARD E Director Grant or award +7,550 37,487
2026-06-10 POST LEONARD E Director Grant or award · Stock Option (Right to Buy) +13,980 13,980
2026-06-10 Kaye Jack Director Grant or award +7,550 27,989
2026-06-10 Kaye Jack Director Grant or award · Stock Option (Right to Buy) +13,980 13,980
2026-06-10 Jacques Rachelle Suzanne Director Grant or award +7,550 35,896
2026-06-10 Jacques Rachelle Suzanne Director Grant or award · Stock Option (Right to Buy) +13,980 13,980
2026-06-10 Balachandran Madhavan Director Grant or award +7,550 45,247
2026-06-10 Balachandran Madhavan Director Grant or award · Stock Option (Right to Buy) +13,980 13,980
2026-06-03 Kaye Jack Director Exercise or conversion 10b5-1 +2,645 $16.04 $42K 23,084
2026-06-03 Kaye Jack Director Sale 10b5-1 −2,645 $30.01 $79K 20,439
2026-06-03 Kaye Jack Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −2,645 0

Page 4 of 13 · 251 trades